Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China
· Delayed Price · Currency is CNY 102.59
+1.84 (1.83%)
At close: Mar 6, 2026
SHA:688198 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 630.37 | 500.26 | 369.91 | 295.07 | 251.8 | Upgrade
|
| Other Revenue | - | 1.61 | 0.73 | 0.1 | 0.02 | Upgrade
|
| Revenue | 630.37 | 501.88 | 370.64 | 295.17 | 251.82 | Upgrade
|
| Revenue Growth (YoY) | 25.60% | 35.41% | 25.57% | 17.21% | 38.42% | Upgrade
|
| Cost of Revenue | - | 58.52 | 37.64 | 31.36 | 29.61 | Upgrade
|
| Gross Profit | 630.37 | 443.35 | 333 | 263.81 | 222.21 | Upgrade
|
| Selling, General & Admin | - | 154.92 | 131.97 | 123.77 | 131.16 | Upgrade
|
| Research & Development | - | 151.44 | 98.81 | 55.15 | 58.9 | Upgrade
|
| Other Operating Expenses | 407 | 3.46 | 1.25 | 1.62 | 1.17 | Upgrade
|
| Operating Expenses | 407 | 312.22 | 233.5 | 181.64 | 192.04 | Upgrade
|
| Operating Income | 223.37 | 131.14 | 99.5 | 82.17 | 30.17 | Upgrade
|
| Interest Expense | - | -0.46 | -0.41 | -0.08 | -0.12 | Upgrade
|
| Interest & Investment Income | - | 17.32 | 17.66 | 22.53 | 16.49 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.05 | -0.26 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -5.86 | -0.16 | -0.06 | -0.68 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | 217.51 | 147.89 | 116.43 | 103.94 | 46.5 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.74 | 1 | 0.89 | 0.97 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.05 | 0.05 | -0.01 | -0.02 | Upgrade
|
| Other Unusual Items | - | 2.2 | 2.54 | 1.32 | 2.31 | Upgrade
|
| Pretax Income | 217.51 | 150.79 | 120.02 | 106.14 | 49.76 | Upgrade
|
| Income Tax Expense | 17.32 | 18.64 | 10.61 | 11.74 | -1.51 | Upgrade
|
| Earnings From Continuing Operations | 200.19 | 132.14 | 109.41 | 94.39 | 51.26 | Upgrade
|
| Minority Interest in Earnings | - | 14.19 | 5.8 | 0.73 | -0.06 | Upgrade
|
| Net Income | 200.19 | 146.33 | 115.21 | 95.13 | 51.2 | Upgrade
|
| Net Income to Common | 200.19 | 146.33 | 115.21 | 95.13 | 51.2 | Upgrade
|
| Net Income Growth | 36.81% | 27.02% | 21.11% | 85.80% | -9.42% | Upgrade
|
| Shares Outstanding (Basic) | 137 | 137 | 136 | 136 | 135 | Upgrade
|
| Shares Outstanding (Diluted) | 137 | 137 | 137 | 136 | 135 | Upgrade
|
| Shares Change (YoY) | 0.26% | -0.29% | 0.92% | 0.86% | 0.44% | Upgrade
|
| EPS (Basic) | 1.46 | 1.07 | 0.85 | 0.70 | 0.38 | Upgrade
|
| EPS (Diluted) | 1.46 | 1.07 | 0.84 | 0.70 | 0.38 | Upgrade
|
| EPS Growth | 36.45% | 27.38% | 20.00% | 84.21% | -9.82% | Upgrade
|
| Free Cash Flow | - | -27.02 | 12.53 | 24.01 | 4.27 | Upgrade
|
| Free Cash Flow Per Share | - | -0.20 | 0.09 | 0.18 | 0.03 | Upgrade
|
| Dividend Per Share | - | 0.800 | 0.800 | 0.500 | 0.357 | Upgrade
|
| Dividend Growth | - | - | 60.00% | 40.02% | 149.90% | Upgrade
|
| Gross Margin | 100.00% | 88.34% | 89.84% | 89.38% | 88.24% | Upgrade
|
| Operating Margin | 35.43% | 26.13% | 26.85% | 27.84% | 11.98% | Upgrade
|
| Profit Margin | 31.76% | 29.16% | 31.08% | 32.23% | 20.33% | Upgrade
|
| Free Cash Flow Margin | - | -5.38% | 3.38% | 8.14% | 1.70% | Upgrade
|
| EBITDA | 242.68 | 150.45 | 110.7 | 87.78 | 36.19 | Upgrade
|
| EBITDA Margin | 38.50% | 29.98% | 29.87% | 29.74% | 14.37% | Upgrade
|
| D&A For EBITDA | 19.31 | 19.31 | 11.19 | 5.61 | 6.02 | Upgrade
|
| EBIT | 223.37 | 131.14 | 99.5 | 82.17 | 30.17 | Upgrade
|
| EBIT Margin | 35.43% | 26.13% | 26.85% | 27.84% | 11.98% | Upgrade
|
| Effective Tax Rate | 7.96% | 12.36% | 8.84% | 11.06% | - | Upgrade
|
| Revenue as Reported | - | 501.88 | 370.64 | 295.17 | 251.82 | Upgrade
|
| Advertising Expenses | - | 2.01 | 0.37 | 1.12 | 1.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.